Blood Level of Phosphoglycerate Kinase Does not Correlate with Presence or Extent of Tumor

Folkman J. . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27–31.

Bergers G. , Benjamin L.E. . Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401–10.

O'Reilly M.S. , Holmgren L. , Shing Y. . Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315–28.

Hogg P.J. . Plasmin reductase. In: Waisman D.M. , ed. Plasminogen. New York: Kluwer Academic Publishers, 2003; 121–31.

Lay A.J. , Jiang X-M , Kisker O. . Phosphoglycerate kinase acts in tumour angiogenesis as a disulfide reductase. Nature 2000; 408: 869–73.

Bhattacharjee A. , Richards W.G. , Staunton J. . Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98: 13790–5.

Chen G. , Gharib T.G. , Wang H. . Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA 2003; 100: 13537–42.

Daly E.B. , Wind T. , Jiang X-M , Sun L. , Hogg P.J. . Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim Biophys Acta 2004; 1691: 41–6.